SCHEMBL25538019

SCHEMBL25538019

CC1(C)c2ccccc2-c2c(-c3cccc(-c4ccc(-c5cc(-c6cccc(-c7cccc8ccccc78)c6)nc(-c6ccccc6)n5)c5ccccc45)c3)cccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.37
HPGD P15428 5/20 0.37
MAPT P10636 5/20 0.37
KDM4E B2RXH2 4/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
TP53 P04637 1/20 0.37
TSHR P16473 1/20 0.37
NFKB1 P19838 1/20 0.37
MAPK1 P28482 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
ATM Q13315 1/20 0.37
HSD17B10 Q99714 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MEN1 O00255 6/20 0.35
KMT2A Q03164 6/20 0.35
SERPINE1 P05121 1/20 0.35
LMNA P02545 3/20 0.34
GLA P06280 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25537970 0.98 ENPP3 (0.36) ALDH1A1HPGDMAPTKDM4ESMN1; SMN2
SCHEMBL25534159 0.98 KDM4E (0.39) ALDH1A1HPGDMAPTKDM4ESMN1; SMN2
SCHEMBL25538087 0.97 ALDH1A1 (0.36) ALDH1A1HPGDMAPTKDM4ESMN1; SMN2
SCHEMBL25537921 0.97 ALDH1A1 (0.36) ALDH1A1HPGDMAPTKDM4ESMN1; SMN2
SCHEMBL25534202 0.96 ENPP1 (0.39) ALDH1A1HPGDMAPTKDM4ESMN1; SMN2
SCHEMBL25534302 0.96 ALDH1A1 (0.36) ALDH1A1HPGDMAPTKDM4ESMN1; SMN2
SCHEMBL25534182 0.96 ALDH1A1 (0.37) ALDH1A1HPGDMAPTKDM4ESMN1; SMN2
SCHEMBL25538021 0.94 KDM4E (0.36) ALDH1A1HPGDMAPTKDM4ESMN1; SMN2
SCHEMBL25534171 0.94 MEN1 (0.35) ALDH1A1HPGDMAPTKDM4ESMN1; SMN2
SCHEMBL25534168 0.94 MEN1 (0.38) ALDH1A1HPGDMAPTKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM ALDH1A1 254/4885HPGD 3854/4885MAPT 1595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.